News & Views | Published:

A stimulating presentation

Nature Biotechnology volume 20, pages 125126 (2002) | Download Citation

Subjects

Engineered artificial antigen-presenting cells provide a defined system for the rapid expansion of cytotoxic T cells used in adoptive immunotherapy.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Nat. Biotechnol. 20, 143–148 (2002).

  2. 2.

    et al. Immunol. Rev. 172, 97–108 (1999).

  3. 3.

    et al. Curr. Opin. Immunol. 10, 581–587 (1998).

  4. 4.

    & J. Immunol. Methods 128, 189–201 (1990).

  5. 5.

    & Curr. Opin. Immunol. 11, 286–293 (1999).

  6. 6.

    et al. J. Immunother. 24, 363–373 (2001).

  7. 7.

    et al. N. Engl. J. Med. 333, 1038–1044 (1995).

  8. 8.

    et al. Blood 92, 1549–1555 (1998).

  9. 9.

    , & J. Immunol. 163, 102–110 (1999).

  10. 10.

    & Nat. Biotechnol. 18, 405–409 (2000).

Download references

Author information

Affiliations

  1. Mark E. Dudley is a research fellow in the Surgery Branch, National Cancer Institute, Bethesda, MD 20892 Mark_Dudley@nih.gov.

    • Mark E. Dudley

Authors

  1. Search for Mark E. Dudley in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt0202-125

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing